رياتاز ١٥٠ ملغ

main_info

  • trade_name:
  • رياتاز ١٥٠ ملغ
  • pharmaceutical_form:
  • CAPSULES
  • administration_route:
  • PER OS
  • medicine_domain:
  • Human
  • medicine_type:
  • Allopathic
  • manufactured_by:
  • BRISTOL MAYERS SQUIBB COMPANY , USA

documents

localization

  • country:
  • رياتاز ١٥٠ ملغ
    إسرائيل
  • language:
  • العربية

therapeutic_information

  • therapeutic_group:
  • ATAZANAVIR
  • therapeutic_indication:
  • Reyataz is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.

status

  • source:
  • Ministry of Health - State of Israel
  • authorization_number:
  • 140783095900
  • authorization_date:
  • 01-05-2009
  • last_update:
  • 09-08-2016

doc_PIL: head_title_medicine_info